Financhill
Sell
21

CDLX Quote, Financials, Valuation and Earnings

Last price:
$1.22
Seasonality move :
8.33%
Day range:
$1.03 - $1.25
52-week range:
$0.85 - $4.24
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.26x
P/B ratio:
1.15x
Volume:
1.3M
Avg. volume:
991.8K
1-year change:
-68.62%
Market cap:
$66.5M
Revenue:
$278.3M
EPS (TTM):
-$2.10

Analysts' Opinion

  • Consensus Rating
    Cardlytics, Inc. has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 4 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $1.63, Cardlytics, Inc. has an estimated upside of 32.11% from its current price of $1.23.
  • Price Target Downside
    According to analysts, the lowest downside price target is $1.50 representing 100% downside risk from its current price of $1.23.

Fair Value

  • According to the consensus of 4 analysts, Cardlytics, Inc. has 32.11% upside to fair value with a price target of $1.63 per share.

CDLX vs. S&P 500

  • Over the past 5 trading days, Cardlytics, Inc. has overperformed the S&P 500 by 2.49% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Cardlytics, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Cardlytics, Inc. revenues have been falling on a year-over-year basis for 6 quarters in a row. In the most recent quarter Cardlytics, Inc. reported revenues of $52M.

Earnings Growth

  • Cardlytics, Inc. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Cardlytics, Inc. reported earnings per share of -$1.36.
Enterprise value:
244M
EV / Invested capital:
1.13x
Price / LTM sales:
0.26x
EV / EBIT:
--
EV / Revenue:
0.97x
PEG ratio (5yr expected):
-0.09x
EV / Free cash flow:
-13.18x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$114.4M
Return On Assets:
-30.53%
Net Income Margin (TTM):
-44.12%
Return On Equity:
-214.96%
Return On Invested Capital:
-40.63%
Operating Margin:
-18.63%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $302.5M $293.5M $251.2M $67.1M $52M
Gross Profit $124.7M $130.7M $114.4M $29.4M $23.6M
Operating Income -$81.1M -$63.1M -$49.8M -$16.9M -$9.7M
EBITDA -$50.7M -$34.7M -$23.1M -$9.3M -$2.7M
Diluted EPS -$12.25 -$6.11 -$2.10 -$2.90 -$1.36
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $335.5M $249.1M $205.6M $183.3M $140.7M
Total Assets $1.2B $1.1B $634.9M $399.4M $292.8M
Current Liabilities $274.5M $254.9M $179.5M $155.9M $123.7M
Total Liabilities $536M $485.8M $409.6M $329.7M $297.5M
Total Equity $688.6M $580.5M $225.3M $69.7M -$4.7M
Total Debt $189.6M $230.8M $230.1M $173.8M $173.7M
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations -$16.2M -$8.9M -$846K $1.4M $1.7M
Cash From Investing -$11.8M -$16M -$17.1M -$5.3M -$4.5M
Cash From Financing -$20.3M $1.7M -$5.2M -$388K --
Free Cash Flow -$28.1M -$27.4M -$18.5M -$3.9M -$2.7M
CDLX
Sector
Market Cap
$66.5M
$53M
Price % of 52-Week High
29.01%
64.06%
Dividend Yield
0%
0%
Shareholder Yield
0.08%
1.13%
1-Year Price Total Return
-68.62%
-6.63%
Beta (5-Year)
1.094
0.328
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Buy
Level $1.19
200-day SMA
Sell
Level $1.80
Bollinger Bands (100)
Sell
Level 1.13 - 2.23
Chaikin Money Flow
Buy
Level 48.8M
20-day SMA
Sell
Level $1.30
Relative Strength Index (RSI14)
Sell
Level 41.38
ADX Line
Sell
Level 34.34
Williams %R
Neutral
Level -60.7843
50-day SMA
Sell
Level $1.81
MACD (12, 26)
Sell
Level -0.17
25-day Aroon Oscillator
Sell
Level -96
On Balance Volume
Neutral
Level 152.9M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (-4.0195)
Sell
CA Score (Annual)
Level (-2.155)
Buy
Beneish M-Score (Annual)
Level (-4.878)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (4.6341)
Buy
Piotroski F Score (Annual)
Level (4)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (4)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Cardlytics, Inc. engages in the business of operating an advertising platform which includes online, mobile applications, email, and various real-time notifications. It operates under the Cardlytics and Bridg Platforms. The Cardlytics Platform segment focuses on the United States and the United Kingdom, which represents proprietary advertising channels. The Bridg Platform segment is involved in utilizing POS data from merchant data partners, including product-level purchase data to enable marketers to perform analytics and targeted loyalty marketing in a privacy protected manner. The company was founded by Scott David Grimes, Lynne Marie Laube, and Hans Theisen on June 26, 2008 and is headquartered in Atlanta, GA.

Stock Forecast FAQ

In the current month, CDLX has received 0 Buy ratings 4 Hold ratings, and 0 Sell ratings. The CDLX average analyst price target in the past 3 months is $1.63.

  • Where Will Cardlytics, Inc. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Cardlytics, Inc. share price will rise to $1.63 per share over the next 12 months.

  • What Do Analysts Say About Cardlytics, Inc.?

    Analysts are divided on their view about Cardlytics, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Cardlytics, Inc. is a Sell and believe this share price will drop from its current level to $1.50.

  • What Is Cardlytics, Inc.'s Price Target?

    The price target for Cardlytics, Inc. over the next 1-year time period is forecast to be $1.63 according to 4 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 4 analysts rate the stock a Hold.

  • Is CDLX A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Cardlytics, Inc. is a Hold. 4 of 4 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of CDLX?

    You can purchase shares of Cardlytics, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Cardlytics, Inc. shares.

  • What Is The Cardlytics, Inc. Share Price Today?

    Cardlytics, Inc. was last trading at $1.22 per share. This represents the most recent stock quote for Cardlytics, Inc.. Yesterday, Cardlytics, Inc. closed at $1.23 per share.

  • How To Buy Cardlytics, Inc. Stock Online?

    In order to purchase Cardlytics, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Google Vs NVIDIA Stock: Which Is Best?
Google Vs NVIDIA Stock: Which Is Best?

Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…

How High Could NVIDIA Stock Go?
How High Could NVIDIA Stock Go?

NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…

Stock Ideas

Buy
51
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 61x

Buy
65
Is AAPL Stock a Buy?

Market Cap: $4.2T
P/E Ratio: 38x

Buy
69
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Sell
47
PSTG alert for Dec 4

Pure Storage, Inc. [PSTG] is up 5.05% over the past day.

Sell
41
SMX alert for Dec 4

SMX (Security Matters) Plc [SMX] is up 154.74% over the past day.

Sell
43
HY alert for Dec 4

Hyster-Yale, Inc. [HY] is up 1.92% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock